Nivolumab plus Ipilimumab: A Novel First-Line Combination Immunotherapy for Unresectable Hepatocellular Carcinoma

Bibliographic Details
Published in:	Liver Cancer
Main Author:	Masatoshi Kudo
Format:	Article
Language:	English
Published:	Karger Publishers 2024-08-01
Subjects:	hepatocellular carcinoma combination immunotherapy nivolumab plus ipilimumab
Online Access:	https://beta.karger.com/Article/FullText/540801

Internet